World’s first clinical trial for a rare headache disorder
The trial will evaluate the efficacy of psilocybin in Short-lasting Unilateral Neuralgiform Headache Attacks (SUNHA). The data is expected in early 2022
The trial will evaluate the efficacy of psilocybin in Short-lasting Unilateral Neuralgiform Headache Attacks (SUNHA). The data is expected in early 2022
Metronidazole Gel USP, 1% is indicated for the topical treatment of inflammatory lesions of rosacea
Idiopathic hypersomnia is a life-long condition, and the approval of Xywav will be instrumental in providing treatment for symptoms such as excessive sleepiness and difficulty waking, and in effectively managing this debilitating disorder
The drug is indicated for mild and transient episodes of heart block
Robust demand for the product across the Middle East, Africa and Latin America
The drug is used with other HIV medications to help control HIV infection and it helps to decrease the amount of HIV in one’s body so that the immune system can work better
It is also used for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection.
Advisory from Apollo Spectra Hospitals highlights hydration, nutrition, and screening as key preventive measures
This combination works to break down rough patches, improve moisture retention, and enhance overall skin texture
The company allocated €56 million to research and development for next-generation line solutions
Subscribe To Our Newsletter & Stay Updated